Max Cryle is an EMBL Australia Group leader at the Monash Biomedicine Discovery Institute and an associate investigator at the Australian Research Council Centre of Excellence in Advanced Molecular Imaging. He obtained his PhD in chemistry from the University of Queensland in 2006 and subsequently worked at the Max Planck Institute for Medical Research as a Cross Disciplinary Fellow. He received funding from the German Research Foundation to start his own group, focusing on glycopeptide antibiotic biosynthesis. Cryle's research intersects chemistry and biology, employing multidisciplinary techniques that include synthetic chemistry, biochemistry, structural biology, and enzyme catalysis. In 2016, he joined EMBL Australia to further investigate natural antibiotic biosynthesis and develop new antimicrobial agents, backed by an NHMRC Career Development Fellowship since 2018.